Robin LaChapelle

Insider Reports History

Entity
Individual
Location
18 Campus Boulevard, Suite 100, Newtown Square, PA
Signature
By: /s/ James Kastenmayer, Attorney-in-Fact For: Robin LaChapelle
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robin LaChapelle:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ArriVent BioPharma, Inc. Chief Operating Officer Common Stock 394K $1.44M $3.65 Sep 19, 2024 Held by The MAKS Yao Trust
ArriVent BioPharma, Inc. Chief Operating Officer Common Stock 125K $455K $3.65 Sep 19, 2024 Direct
ArriVent BioPharma, Inc. Chief Operating Officer Stock Option (right to buy) 56.5K Sep 19, 2024 Direct

Insider Reports Filed by Robin LaChapelle

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVBP ArriVent BioPharma, Inc. Sep 19, 2024 10 $90.5K 4 Sep 23, 2024 Chief Operating Officer
AVBP ArriVent Biopharma, Inc. Jan 25, 2024 0 $0 3 Jan 25, 2024 Chief Operating Officer